3,378
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Visualization of chikungunya virus infection in vitro and in vivo

, , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 1574-1583 | Received 27 May 2019, Accepted 12 Sep 2019, Published online: 04 Nov 2019

References

  • Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010;8:491–500. doi: 10.1038/nrmicro2368
  • Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond). 1956;54:177–191. doi: 10.1017/S0022172400044442
  • Weaver SC, Forrester NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res. 2015;120:32–39. doi: 10.1016/j.antiviral.2015.04.016
  • Deng CL, Liu SQ, Zhou DG, et al. Development of neutralization assay using an eGFP Chikungunya virus. Viruses. 2016;8:7. doi: 10.3390/v8070181
  • Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263. doi: 10.1371/journal.pmed.0030263
  • Tsetsarkin KA, Vanlandingham DL, McGee CE, et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3:e201. doi: 10.1371/journal.ppat.0030201
  • Dash AP, Bhatia R, Sunyoto T, et al. Emerging and re-emerging arboviral diseases in Southeast Asia. J Vector Borne Dis. 2013;50:77–84.
  • Schoggins JW, Dorner M, Feulner M, et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A. 2012;109:14610–14615. doi: 10.1073/pnas.1212379109
  • Li XF, Li XD, Deng CL, et al. Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling. Theranostics. 2017;7:912–925. doi: 10.7150/thno.16615
  • Heaton NS, Leyva-Grado VH, Tan GS, et al. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol. 2013;87:8272–8281. doi: 10.1128/JVI.00969-13
  • Cook SH, Griffin DE. Luciferase imaging of a neurotropic viral infection in intact animals. J Virol. 2003;77:5333–5338. doi: 10.1128/JVI.77.9.5333-5338.2003
  • Burke CW, Mason JN, Surman SL, et al. Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. PLoS Pathog. 2011;7:e1002134. doi: 10.1371/journal.ppat.1002134
  • Luker GD, Bardill JP, Prior JL, et al. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol. 2002;76:12149–12161. doi: 10.1128/JVI.76.23.12149-12161.2002
  • Luker KE, Hutchens M, Schultz T, et al. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology. 2005;341:284–300. doi: 10.1016/j.virol.2005.06.049
  • Nogales A, Baker SF, Martinez-Sobrido L. Replication-competent influenza A viruses expressing a red fluorescent protein. Virology. 2015;476:206–216. doi: 10.1016/j.virol.2014.12.006
  • Tran MT, Tanaka J, Hamada M, et al. In vivo image analysis using iRFP transgenic mice. Exp Anim. 2014;63:311–319. doi: 10.1538/expanim.63.311
  • Filonov GS, Piatkevich KD, Ting LM, et al. Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol. 2011;29:757–761. doi: 10.1038/nbt.1918
  • Jiguet-Jiglaire C, Cayol M, Mathieu S, et al. Noninvasive near-infrared fluorescent protein-based imaging of tumor progression and metastases in deep organs and intraosseous tissues. J Biomed Opt. 2014;19:16019. doi: 10.1117/1.JBO.19.1.016019
  • Isomura M, Yamada K, Noguchi K, et al. Near-infrared fluorescent protein iRFP720 is optimal for in vivo fluorescence imaging of rabies virus infection. J Gen Virol. 2017;98:2689–2698. doi: 10.1099/jgv.0.000950
  • Meier KC, Gardner CL, Khoretonenko MV, et al. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 2009;5:e1000614. doi: 10.1371/journal.ppat.1000614
  • Noisakran S, Onlamoon N, Hsiao HM, et al. Infection of bone marrow cells by dengue virus in vivo. Exp Hematol. 2012;40:250–259 e4. doi: 10.1016/j.exphem.2011.11.011
  • Iyer SM, Montgomery KL, Towne C, et al. Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice. Nat Biotechnol. 2014;32:274–278. doi: 10.1038/nbt.2834
  • Langsjoen RM, Haller SL, Roy CJ, et al. Chikungunya virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models. MBio. 2018;9:2. doi: 10.1128/mBio.02449-17
  • Wang E, Kim DY, Weaver SC, et al. Chimeric chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response. J Virol. 2011;85:9249–9252. doi: 10.1128/JVI.00844-11
  • Ziegler SA, Nuckols J, McGee CE, et al. In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis. 2011;11:1471–1477. doi: 10.1089/vbz.2011.0648
  • Weaver SC, Osorio JE, Livengood JA, et al. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines. 2012;11:1087–1101. doi: 10.1586/erv.12.84
  • Kummerer BM, Grywna K, Glasker S, et al. Construction of an infectious chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites. J Gen Virol. 2012;93:1991–1995. doi: 10.1099/vir.0.043752-0
  • Sun C, Gardner CL, Watson AM, et al. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J Virol. 2014;88:2035–2046. doi: 10.1128/JVI.02990-13
  • Poussard A, Patterson M, Taylor K, et al. In vivo imaging systems (IVIS) detection of a neuro-invasive encephalitic virus. J Visualized Exp. 2012;70:e4429.
  • Palha N, Guivel-Benhassine F, Briolat V, et al. Real-time whole-body visualization of chikungunya virus infection and host interferon response in zebrafish. PLoS Pathog. 2013;9:e1003619. doi: 10.1371/journal.ppat.1003619
  • Nuckols JT, Ziegler SA, Huang YJ, et al. Infection of Aedes albopictus with chikungunya virus rectally administered by enema. Vector Borne Zoonotic Dis. 2013;13:103–110. doi: 10.1089/vbz.2012.1013
  • Zou G, Xu HY, Qing M, et al. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res. 2011;91:11–19. doi: 10.1016/j.antiviral.2011.05.001
  • Couderc T, Chretien F, Schilte C, et al. A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4:e29. doi: 10.1371/journal.ppat.0040029
  • Ziegler SA, Lu L, da Rosa AP, et al. An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg. 2008;79:133–139. doi: 10.4269/ajtmh.2008.79.133
  • Tsetsarkin K, Higgs S, McGee CE, et al. Infectious clones of chikungunya virus (La Reunion isolate) for vector competence studies. Vector Borne Zoonotic Dis. 2006;6:325–337. doi: 10.1089/vbz.2006.6.325